Screening performance on adenoma and advanced neoplasia detection is consistent among radiologists using metrics that included advanced neoplasia detection rate and per-polyp endoscopic confirmation rate.
Before Medicare halted coverage for screening CT colonography in March 2009, the technique was indeed being used appropriately, a study has found.
High-quality CT colonoscopy diagnostic images can be maintained while reducing the radiation dose, according to a new study.
A new modeling study has found that people who undergo colonoscopy at age 50 years in which no precancerous polyps are found can be rescreened at age 60 years with one of three alternative methods, rather than undergoing colonoscopy every 10 years.
It may be reasonable to use methods other than colonoscopy to rescreen people who had negative results on their first screening colonoscopy.
CT colonography can accurately detect adenomas 10 mm or larger in patients who did not undergo laxative-induced bowel cleansing before the procedure.
CT colonography accurately detects cancer and precancerous polyps in persons aged 65 years and older.
Less accurate for smaller lesions; better patient scores for comfort, exam preparation.
Offering CT colonography improved participation in colorectal cancer screening by more than 50% compared with colonoscopy, but colonoscopy identified significantly more advanced neoplasia.
Computed tomographic colonography (CTC) is gaining a foothold in US hospitals despite lack of Medicare coverage or national consensus on its role in colorectal cancer screening.
Costs of computed tomography colonography (CTC) discourage patients who have previously refused colorectal cancer screening, according to a study published in the American Journal of Roentgenology (2010 Aug;195(2):393-7).
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|